New China net Xiamen on August 28 special news (by Yu Yingrui) recently, how Xiamen University life sciences dean Professor Lin Shengcai topic-based group’s research results promulgated the cell to prevent the cancer the inherent mechanism, this is a cancer new breakthrough.
Said from the medicine that the cancer had a very important reason is because the cell genome team had the sudden change, subsequently presents the cell growth and fission unusuality, and will have the flaw genetic material to transmit, organized the appearance until the cancer.
Professor Lin Shengcai the research of topic-based group indicated that exists in the cell one kind of named Axin protein member may through controlling one kind of named p53 oncogene activeness either decided cell “destiny”, this means included excessive damage gene cell “destiny” to be possible to urge cell through two specific interaction “death”, thus avoided the ontogenesis cancer. This discovery possibly provides the new mentality and way for cancer treatment.
This newest research results on August 23 published in international prestigious academic journal “Nature – Cytobiology” on, this magazine was the British Nature sub-publication, is considered that was the cytobiology domain apex magazine.
According to the topic-based group members and Xiamen University life sciences Institute associate professor Li Qinxi, Professor Lin Shengcai is the cytobiology and tumor cell project Ministry of Education key laboratory and Fujian tumor biology key laboratory director, he leads the topic-based group devotes for a long time to the cellular biology of tumor research, and has discovered between relations Axin and p53 exclusive. Before this, the topic-based group has published a series article in some international prestigious academic journals, but the occurrence and the development cancer are extremely complex, the publication of this research result is in a research development achievement, the topic-based group is also only going further profoundly to study.
Comments
Leave a comment Trackback